Sources | Names Used |
---|---|
CCLE, GRAY | PF-2341066 |
GDSC1000, FIMM | Crizotinib |
gCSI, CTRPv2 | crizotinib |
PharmacoGx | Crizotinib |
Database | Identifier |
---|---|
Smiles: | CC(C1=C(C=C(C=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N |
Inchikey: | SCJHEFQWKWHQTO-GFCCVEGCSA-N |
Pubchem: | 54613769 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ALK | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | FBRSL1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | AMT | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | GLTSCR2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | TMEM260 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | NKG7 | CCLE | pan-cancer | AAC | 0.23 | 4e-06 |
mRNA | EEF2 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | CTDP1 | CCLE | pan-cancer | AAC | 0.23 | 4e-06 |
mRNA | DST | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
mRNA | FBXL13 | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-06 |